What Is Value-Based Care

By Kevin Fernando · Sep 28, 2026 · 12 min read

Value-based care is a healthcare payment model that links what providers earn to the results they achieve for patients, measured through quality, equity, and cost metrics, rather than paying them for each service delivered. It shifts financial incentives from volume to outcomes.

For decades, American healthcare operated on a straightforward financial model: providers earned money by delivering services. A doctor's office visit, a hospital admission, a surgical procedure, a diagnostic test, each generated a payment. The more services delivered, the more revenue earned. This arrangement, called fee-for-service, created a misalignment: providers had financial incentives to increase volume regardless of whether additional services improved patient health.

Value-based care inverts that logic. Instead of paying for volume, payers tie provider revenue to the results care produces. A hospital that reduces readmissions earns more. A doctor's practice that manages chronic disease more effectively shares in the savings. This shift changes which decisions providers make and which outcomes they prioritize. Understanding how value-based care works, and what it actually measures, is essential for anyone tracking healthcare policy, analyzing health systems, or researching how payment models shape clinical practice.

What value-based care actually is

Value-based care is a payment model in which providers earn based on the outcomes they achieve for patients rather than the volume of services they deliver. The term encompasses a range of payment arrangements, but they share a core principle: financial reward ties to measurable results.

CMS defines value-based care as healthcare designed to focus on quality, provider performance, and patient experience. The "value" in the term refers to what an individual patient values most. In practice, this means doctors and other healthcare providers work together to manage a person's overall health while considering that individual's personal health goals. The shift is structural: instead of a provider billing for each encounter or procedure, they earn payment, or a portion of payment, contingent on whether care meets specified outcome targets.

How value-based care payment works

Value-based care payment operates through three main mechanisms: pay-for-performance incentives, shared savings payments, and upfront payments. Each ties provider earnings to outcome achievement, but the mechanics differ.

Under a pay-for-performance model, a provider receives a bonus if it meets quality benchmarks. Under a shared savings model, a provider or provider group shares in cost reductions they generate relative to a spending benchmark. Under an upfront payment model, a provider receives a fixed payment per patient and manages all care within that budget, bearing the financial risk if costs exceed the payment.

Suppose a hospital participates in a shared savings program with a spending benchmark of $10,000 per patient per year. If the hospital delivers care for $9,000 per patient, it has generated $1,000 in savings per patient. If the shared savings rate is 50%, the hospital keeps $500 per patient as additional revenue. If it serves 10,000 patients, that amounts to $5 million in shared savings. The financial incentive is clear: the hospital earns more by reducing unnecessary spending while maintaining or improving quality.

The shift from fee-for-service

Under fee-for-service, a provider receives a set payment for each service: a visit, a test, a procedure. The payment is independent of the outcome. A patient admitted to the hospital generates revenue whether the admission prevents a worse outcome or whether it was unnecessary. A diagnostic test generates payment whether its result changes treatment or not.

Value-based care removes that automatic payment. In many arrangements, the underlying fee-for-service structure remains, but it is modified. Providers may receive their standard per-service payments but face payment reductions if they fail to meet outcome targets, or they may share in savings if they exceed them. In other arrangements, the fee-for-service layer disappears entirely and providers operate under capitation or bundled payments, where they receive a fixed amount per patient or per episode regardless of how many services they deliver.

The consequence is that volume no longer guarantees revenue. A provider that orders more tests, admits more patients, or performs more procedures without improving outcomes does not earn more under value-based payment. This breaks the financial incentive that historically encouraged overutilization.

Outcome metrics and payment adjustment

Value-based programs measure specific outcomes and tie payment adjustments to performance on those measures. The outcomes tracked vary by program and setting, but common metrics include hospital readmission rates, infection rates, patient experience scores, and total cost of care.

For example, the Hospital Readmissions Reduction Program includes 30-day risk-standardized unplanned readmission measures for conditions such as acute myocardial infarction. If a hospital's readmission rate exceeds the benchmark, it faces a payment penalty. If it performs better than the benchmark, it may receive no penalty or a bonus depending on the program structure.

The Hospital Value-Based Purchasing Program rewards acute care hospitals with incentive payments for the quality of care provided in the inpatient hospital setting. The program's stated intent includes reducing mortality and complications, reducing healthcare-associated infections, increasing patient safety, improving patient experience, and increasing efficiency and reducing costs. Hospitals are scored on measures aligned with these goals, and payment adjustments, increases or decreases, flow from those scores.

Similarly, the Skilled Nursing Facility Value-Based Purchasing Program awards incentive payments based on performance on quality measures, including the 30-day all-cause readmission measure. The mechanics are consistent across settings: measure performance, compare it to a benchmark or peer group, and adjust payment accordingly.

Why value-based care changes provider incentives

When payment depends on outcomes rather than volume, providers make different clinical and operational decisions. The financial incentive shifts from "do more" to "do better."

Under fee-for-service, a provider benefits from admitting a patient to the hospital because admission generates revenue. Under value-based care with shared savings or capitation, an unnecessary admission reduces profitability because it increases costs without improving outcomes. The provider now has financial reason to manage the patient in a lower-cost setting if clinically appropriate.

Similarly, under fee-for-service, a provider benefits from ordering additional diagnostic tests because each test generates a separate payment. Under value-based care, additional tests increase costs without necessarily improving outcomes. The provider now has financial reason to order only tests that change management.

These incentives also encourage coordination. When providers share financial risk around a patient population, they have reason to communicate, share data, and align treatment decisions. A primary care doctor and a specialist have shared financial interest in avoiding redundant testing or conflicting treatment plans. Under fee-for-service, each provider operates independently and bears no financial consequence for duplication or misalignment.

Value-based payment also creates incentives for prevention and chronic disease management. If a provider receives a fixed payment per patient and bears financial risk for high costs, preventing expensive acute events becomes profitable. Investing in diabetes management, hypertension control, and preventive screening reduces the likelihood of costly complications. Under fee-for-service, prevention generates no revenue; it only reduces the volume of billable services.

Common value-based care models in practice

Several distinct structural models implement value-based payment principles. Understanding the differences helps readers recognize these arrangements in policy reporting and market analysis.

Accountable Care Organizations (ACOs) are groups of doctors, hospitals, and other healthcare professionals that work together to give patients high-quality, coordinated service and healthcare, improve health outcomes, and manage costs. In most ACOs, the providers do not know which patients will be included in the special payment arrangement until after services are delivered through retrospective assignment. Most ACOs have been paid through a shared savings program in which there is no change to the underlying fee-for-service payment structure for the providers in the ACO. The ACO model is the largest value-based arrangement in Medicare. As of 2024, 480 ACOs participated in the Medicare Shared Savings Program, covering about 13.7 million people with Traditional Medicare. Providers in ACOs share in savings achieved through improved care efficiency, with shared savings rates typically ranging from 25% to 75% of the savings generated below the benchmark.

Bundled payments cover all services related to a specific episode of care, for example, a joint replacement surgery including the procedure, hospital stay, and post-operative rehabilitation. The provider or provider group receives a fixed payment for the entire episode and keeps any savings if costs run below the bundle price, or absorbs losses if costs exceed it.

Capitation involves paying a provider a fixed amount per patient per month or per year, regardless of how many services the patient receives. The provider manages all care within that payment and bears full financial risk for costs exceeding the capitated amount.

Shared savings programs, like those used by most ACOs, keep the fee-for-service payment structure intact but add a layer of shared upside: if the provider group reduces total spending below a benchmark, they share in the savings. There is typically no downside risk; providers do not lose money if spending exceeds the benchmark, though some newer models include two-sided risk where providers also share in losses.

Clinically Integrated Networks (CINs) use shared data systems to align care practices and ensure that providers meet quality benchmarks, typically tracking 10-30 clinical quality measures tied to payer contract performance bonuses that can represent 2-5% of total contracted revenue.

What value-based care does and does not measure

Value-based care programs measure outcomes that are specific, quantifiable, and tied to payment. This creates a powerful incentive to improve those particular metrics. But the outcomes that are easy to measure are not always the outcomes that matter most to patients or that reflect the full impact of care.

Outcomes that are easy to measure versus outcomes that matter

Hospital readmission rates are easy to measure: a readmission either occurs or it does not, within a defined timeframe, and the data exist in billing records. Infection rates are easy to measure: infections are documented in medical records and coded in administrative data. Patient experience scores are easy to measure: surveys generate numerical ratings. Cost is easy to measure: billing data provide exact figures. These metrics drive payment in value-based programs because they are objective, verifiable, and available at scale.

But consider what patients actually care about. Does a patient with diabetes value a lower readmission rate, or do they value better control of their blood sugar, less fatigue, the ability to return to work, and confidence in managing their condition? Does a patient recovering from surgery value a lower infection rate, or do they value pain control, rapid return to normal function, and minimal scarring? Does a patient with heart disease value a lower mortality rate, or do they value being able to climb stairs without shortness of breath, maintaining independence, and living longer with good quality of life?

The outcomes that are easy to measure, readmissions, infections, mortality, cost, are proxies for what patients care about. They are correlated with better outcomes, and in many cases they are important. But they are not identical to the outcomes patients prioritize. A provider that reduces readmissions through better medication adherence support and closer follow-up is likely improving what patients care about. A provider that reduces readmissions by being more selective about which patients it admits, while providing no additional support to those admitted, may be gaming the metric without improving patient function or quality of life.

This gap between measurable outcomes and meaningful outcomes creates a fundamental tension in value-based care. Programs can only pay based on what they can measure. But what they measure may not fully capture what matters.

Gaming and unintended consequences

When payment hinges on specific metrics, providers have financial incentive to improve those metrics. If the incentive is strong enough and the metric is poorly designed, providers may improve the metric without improving actual care or may even harm care in unmeasured dimensions.

Consider a readmission metric. A provider could reduce readmissions by improving discharge planning, medication reconciliation, and follow-up, genuine improvements in care quality. Or a provider could reduce readmissions by being more selective about which patients it admits to the hospital in the first place, shifting sicker patients to competitors. The readmission rate improves either way, but only the first approach benefits patients.

Or consider a cost metric. A provider could reduce costs by eliminating unnecessary tests and procedures, a genuine efficiency gain. Or a provider could reduce costs by denying or delaying care that patients need, harming outcomes in dimensions the program does not measure. Again, the cost metric improves either way.

These gaming behaviors emerge when three conditions align: the metric is important to payment, the metric can be manipulated without being detected, and the manipulation is easier than genuine improvement. Well-designed value-based programs mitigate this risk through several mechanisms: measuring multiple outcomes so providers cannot game one metric without affecting others; risk-adjusting metrics to account for patient severity so providers cannot improve metrics simply by avoiding sick patients; and including outcome measures that are harder to game, such as mortality or functional status, alongside easier-to-game metrics like utilization.

But no set of metrics is perfect. Every measurement system has blind spots, and financial incentives will eventually find them.

How value-based care connects to healthcare costs and access

Policymakers pursue value-based care primarily to address two problems: rising healthcare costs and unequal access to high-quality care.

On cost, the logic is straightforward. Fee-for-service payment rewards volume, which encourages unnecessary services and drives spending up. Value-based payment rewards efficiency, which should reduce unnecessary services and moderate spending growth. By aligning provider incentives with cost control, value-based models aim to reduce total spending without reducing care quality. The evidence on whether this works varies by model and setting, but the principle is clear: changing payment changes behavior, and behavior change can affect costs.

On access and quality, value-based care aims to address the fragmentation of fee-for-service medicine. When each provider operates independently and earns per service, there is no incentive to coordinate care, share information, or ensure continuity. Patients navigate a fragmented system where their primary care doctor does not know what their specialist prescribed, where redundant tests occur, and where gaps in care are common. Value-based models that tie payment to population health outcomes create incentives for coordination, information sharing, and continuity. Providers in an ACO share financial risk around a patient population, so they have reason to work together to manage that population's health.

However, value-based care does not automatically improve access. If value-based payment incentivizes providers to avoid sicker or more complex patients, because those patients are more expensive and harder to manage, access for those populations could worsen. This is why risk adjustment is critical: if payments are adjusted for patient severity, providers have no financial advantage to avoiding sick patients. But risk adjustment is imperfect, and gaming remains possible.

Value-based care also does not guarantee lower costs for patients. Providers may reduce unnecessary services, but they may also shift costs to patients through higher out-of-pocket payments or narrower networks. The impact on patient access and affordability depends on how the savings from reduced unnecessary services are distributed and whether patients face higher cost-sharing.

Value-based care and adjacent payment models

Value-based care exists within a landscape of payment models, some of which overlap with it or share similar characteristics. Distinguishing value-based care from adjacent models helps readers recognize different arrangements in policy and market reporting.

Difference between value-based care and risk-based contracting

Value-based care and risk-based contracting are related but distinct. Value-based care ties payment to measured outcomes, quality, cost, patient experience. Risk-based contracting ties payment to financial risk: the provider bears some or all of the financial risk if costs exceed a target.

These concepts overlap but are not identical. A shared savings program is both value-based and risk-based: providers share in savings (value-based) and bear some downside risk if they fail to achieve savings (risk-based). Capitation is risk-based: the provider bears full financial risk. But capitation may or may not be value-based: if the capitated payment is the only payment and outcomes are not measured or tied to additional payment, capitation is risk-based but not value-based in the sense of tying payment to measured outcomes.

Fee-for-service with quality bonuses is value-based but not risk-based: providers earn bonuses for meeting quality targets, but they do not bear financial risk if they fail to meet targets; they simply do not earn the bonus.

The distinction matters because risk-based contracting creates financial incentives even without outcome measurement. A provider bearing financial risk for total costs has incentive to reduce costs regardless of whether specific outcomes are measured. But that incentive may lead to cost reduction through genuine efficiency or through gaming, denial of care, or patient selection. Value-based care adds outcome measurement to the financial incentive, creating accountability for what the cost reduction achieves. A well-designed value-based program combines risk-based payment with measured outcomes, so providers bear financial risk for costs but must achieve that cost reduction while meeting quality and outcome targets.

Do this automatically

Calculating the cost of manually tracking outcome metrics across multiple value-based care programs, reviewing patient data, adjusting payments based on performance thresholds, and reconciling results across different payers, requires significant administrative time multiplied by the frequency of measurement cycles and the number of patients enrolled. Software can automate these calculations and consolidate performance data across programs, reducing the manual effort required to manage value-based payment arrangements. Healthcare research runs this kind of analysis end to end and cites every figure back to its original source, across as many subjects as you need, with Mimir attaching a citation to every figure. It will not predict a trial's outcome or advise on anyone's treatment. Those decisions stay with clinicians and regulators, and deliberately so. Every plan includes it, including the free one.

Start your first report and run it on something you already know well.

This article is general information about healthcare and life-sciences topics. It is not medical advice, diagnosis, or treatment guidance, and it is not a substitute for a qualified professional. Any treatment decision should be discussed with a clinician.